Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
Trackers› Clinical trials› Katowice
Clinical trial register · Poland

Clinical Trials in Katowice, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Poland and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 2705 matching records held by the registry are in this view. Synced 28 Oct 2026, 03:18 UTC
2705
Studies in scope
all four open statuses
1389
Recruiting now
open to new participants
512
Lead sponsors
across recruiting studies
Top sites
Katowice 16 Warsaw 14 Krakow 12 Bydgoszcz 11 Lublin 10
Narrow the registerReset
Recruitment status
Phase
Site location
Katowice16 Warsaw14 Krakow12 Bydgoszcz11 Lublin10
All 22 locations
Target enrolment
to

Trials with a site in Katowice

16 of 2705 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Poland
Start
Recruiting
argenx
Phase 3
230
Krakow, Katowice, Bydgoszcz, Chrzanów, Lublin, Warsaw, Zamość
2026-06-10
Recruiting
argenx
Phase 2
70
Bydgoszcz, Katowice, Warsaw
2025-12-19
Recruiting
argenx
Observational
70
Bydgoszcz, Krakow, Katowice, Warsaw
2025-12-19
Recruiting
A Study to Assess the Efficacy and Safety of Empasiprubart in Adults With CIDP
NCT07091630Chronic Inflammatory Demyelinating Polyneuropathy, CIDP, Chronic Inflammatory Demyelinating Polyradiculoneuropathy
argenx
Phase 3
160
Katowice, Krakow, Warsaw
2025-09-16
Recruiting
A Study to Assess Efficacy and Safety of Empasiprubart Versus IVIg in Adults With CIDP
NCT06920004Chronic Inflammatory Demyelinating Polyneuropathy, CIDP, CIDP - Chronic Inflammatory Demyelinating Polyneuropathy
argenx
Phase 3
218
Bydgoszcz, Katowice, Krakow, Lublin, Poznan, Rzeszów, Szczecin, Warsaw
2025-08-22
Active, closed
argenx
Phase 3
631
Bialystok, Bydgoszcz, Częstochowa, Elblag, Gdynia, Grodzisk Mazowiecki, Katowice, Krakow
2025-01-15
Active, closed
argenx
Phase 3
154
Bydgoszcz, Katowice, Krakow, Lublin, Warsaw
2024-12-18
Recruiting
argenx
Phase 3
69
Bydgoszcz, Katowice, Lodz, Lublin, Nowy Sącz, Torun
2024-10-18
Active, closed
argenx
Phase 3
141
Bydgoszcz, Katowice, Krakow, Lublin
2024-09-18
Recruiting
argenx
Phase 2/3
12
Gdansk, Katowice, Warsaw
2024-06-28
Active, closed
argenx
Phase 3
119
Bydgoszcz, Katowice, Krakow, Lublin, Wroclaw
2024-04-16
Recruiting
argenx
Observational
100
Bydgoszcz, Katowice, Warsaw
2024-02-13
Active, closed
argenx
Observational
413
Bydgoszcz, Katowice, Krakow, Lublin, Warsaw
2023-11-29
Active, closed
argenx
Phase 3
173
Katowice, Nowy Sącz, Skorzewo
2021-11-17
Recruiting
argenx
Phase 2/3
12
Gdansk, Katowice, Warsaw
2021-10-26
Rows per page Showing 1–16 of 16
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Polish investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 28 October 2026. https://priyalifescience.com/clinical-trials-poland/city/katowice

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Poland and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 2,705 studies in total at the last sync on 28 Oct 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 16 of those studies with a site in Katowice that also match the filters currently applied.

How many clinical trials are recruiting in Katowice?

9 of the 16 studies on this page are recruiting new participants as of the 28 Oct 2026, 03:18 UTC sync. A further 0 have not yet opened recruitment, 6 are active but closed to new participants, and 1 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Katowice), 16 studies
PhaseStudiesRecruitingShare
Phase 39456.3%
Observational3218.8%
Phase 2/33218.8%
Phase 2116.3%

Most active sponsors

Lead sponsors with the most studies (Katowice)
Lead sponsorStudiesRecruiting
argenx169
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.